Education
About Us
Working with TipRanks
Follow Us
Cann Group Ltd. (CNGGF)
OTHER OTC:CNGGF
CNGGF Stock Chart & Stats
$0.02
$0.02(193.50%)
At close: 4:00 PM EST
$0.02
$0.02(193.50%)
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume2.50K
Average Volume (3M)1.42K
Market Cap
$8.93M
Enterprise Value$82.16M
Total Cash (Recent Filing)$10.00K
Total Debt (Recent Filing)$75.84M
Price to Earnings (P/E)―
Beta13.12
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,588,366,700
10 Day Avg. Volume2,572
30 Day Avg. Volume1,422
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.90
Price to Sales (P/S)0.40
P/FCF Ratio-0.54
Enterprise Value/Market Cap9.20
Enterprise Value/Revenue6.20
Enterprise Value/Gross Profit-22.01
Enterprise Value/Ebitda-9.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated Supply ChainOwning cultivation, manufacturing and distribution provides durable operational control over product quality, regulatory compliance and supply reliability. This vertical integration can sustain margins, shorten time-to-market for new products, and support scaling into new markets over months.
Research Partnerships And LicensingActive collaborations and licensing efforts build a longer-term product pipeline and alternative revenue streams beyond patient sales. Such partnerships can lower R&D cost, accelerate clinical development, and create durable strategic options for commercial or co-development deals.
Positive Gross Margin At Product LevelA reported gross margin near 39% indicates product-level economics are viable, implying cost-efficient cultivation and processing. If overheads and operating losses are addressed, this gross profitability supports sustainable unit economics and potential profit conversion as revenue stabilises.
Bears Say
Negative Equity / Solvency RiskNegative shareholders' equity and extreme leverage signal structural solvency risk and constrain access to inexpensive capital. Over a multi-month horizon this limits strategic flexibility, increases refinancing risk, and may force dilutive or costly funding solutions to sustain operations.
Deep Operating Losses And Shrinking RevenueSteep revenue decline coupled with very large negative EBIT and net margins reflect structural profitability issues. Persistent operating losses reduce reinvestment capacity, require external funding or restructuring, and undermine long-term viability unless revenue trends reverse and costs are materially cut.
Negative Cash GenerationOngoing negative operating cash flow and deteriorating free cash flow growth indicate sustained cash burn. Over months this impairs the company's ability to fund operations internally, increases reliance on external financing, and raises execution risk for product development and market expansion plans.
Cann Group News
CNGGF FAQ
What was Cann Group Ltd.’s price range in the past 12 months?
Cann Group Ltd. lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Cann Group Ltd.’s market cap?
Cann Group Ltd.’s market cap is $8.93M.
When is Cann Group Ltd.’s upcoming earnings report date?
Cann Group Ltd.’s upcoming earnings report date is Feb 26, 2026 which is in 22 days.
How were Cann Group Ltd.’s earnings last quarter?
Cann Group Ltd. released its earnings results on Aug 29, 2025. The company reported -$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.014.
Is Cann Group Ltd. overvalued?
According to Wall Street analysts Cann Group Ltd.’s price is currently Overvalued.
Does Cann Group Ltd. pay dividends?
Cann Group Ltd. does not currently pay dividends.
What is Cann Group Ltd.’s EPS estimate?
Cann Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cann Group Ltd. have?
Cann Group Ltd. has 1,588,366,700 shares outstanding.
What happened to Cann Group Ltd.’s price movement after its last earnings report?
Cann Group Ltd. reported an EPS of -$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cann Group Ltd.?
Currently, no hedge funds are holding shares in CNGGF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cann Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
CNGGF Sentiment 70%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-401.36%
Trailing 12-Months
Asset Growth
-16.66%
Trailing 12-Months
Company Description
Cann Group Ltd.
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---